Renowned as experts in drowsiness/wakefulness detection, Optalert is now exploring new pathways in the automotive industry, pharmaceutical drug trials and neurological research. Sign up today to keep up to date with the latest news from Optalert.
Dr Murray John’s latest publication – Now available
The Assessment of ‘Sleepiness’ in Human Drug Trials: A New Perspective
Current Psychopharmacology 2019, Volume 8 , Issue 1
Mining / Road Transport
Optalert’s early warning drowsiness detection technology, protecting industry for over 20 years. Improved safety, with maximum productivity.
Automotive
Optalert’s automotive video camera system. The smart blink system for detecting and monitoring drowsiness/alertness performance.
Pharmaceutical
BlinQ system, the next generation in measuring drowsiness/wakefulness in clinical drug trials. Determine efficacy, safety and the right dose.
Neurology Research
Optalert gives researchers the potential to identify, track and detect precursors or changes in neurological disorders for early intervention.
OPTALERT’S EARLY-WARNING SYSTEM IS TRUSTED BY MAJOR GLOBAL BLUE CHIP COMPANIES
